Published in BMC Nephrol on August 10, 2012
Markers of renal disease and function are associated with systemic inflammation in HIV infection. HIV Med (2015) 0.81
Elevation of Non-Classical (CD14+/lowCD16++) Monocytes Is Associated with Increased Albuminuria and Urine TGF-β1 in HIV-Infected Individuals on Stable Antiretroviral Therapy. PLoS One (2016) 0.75
Urinary Markers of Tubular Injury in HIV-Infected Patients. Biochem Res Int (2016) 0.75
Relationships between renal parameters and serum and urine markers of inflammation in those with and without HIV infection. AIDS Res Hum Retroviruses (2015) 0.75
Predictive factors and prevalence of microalbuminuria in HIV-infected patients: a cross-sectional analysis. BMC Nephrol (2017) 0.75
CD4+ count-guided interruption of antiretroviral treatment. N Engl J Med (2006) 22.76
2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens (2007) 20.09
Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet (2005) 13.77
Tenofovir-associated acute and chronic kidney disease: a case of multiple drug interactions. Clin Infect Dis (2005) 3.76
Guidelines for the management of chronic kidney disease in HIV-infected patients: recommendations of the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis (2005) 3.63
Randomized comparison of renal effects, efficacy, and safety with once-daily abacavir/lamivudine versus tenofovir/emtricitabine, administered with efavirenz, in antiretroviral-naive, HIV-1-infected adults: 48-week results from the ASSERT study. J Acquir Immune Defic Syndr (2010) 2.85
Estimated glomerular filtration rate, chronic kidney disease and antiretroviral drug use in HIV-positive patients. AIDS (2010) 2.85
Association between ABCC2 gene haplotypes and tenofovir-induced proximal tubulopathy. J Infect Dis (2006) 2.72
Association between kidney function and albuminuria with cardiovascular events in HIV-infected persons. Circulation (2010) 2.71
The clinical epidemiology and course of the spectrum of renal diseases associated with HIV infection. Kidney Int (2004) 2.60
A cross-sectional study of HIV-seropositive patients with varying degrees of proteinuria in South Africa. Kidney Int (2006) 2.35
Microalbuminuria in HIV infection. AIDS (2007) 2.28
Renal tubular dysfunction associated with tenofovir therapy: report of 7 cases. J Acquir Immune Defic Syndr (2004) 2.12
Highly active antiretroviral therapy and the incidence of HIV-1-associated nephropathy: a 12-year cohort study. AIDS (2004) 2.11
Development of proteinuria or elevated serum creatinine and mortality in HIV-infected women. J Acquir Immune Defic Syndr (2003) 2.11
Chronic renal failure among HIV-1-infected patients. AIDS (2007) 2.07
British HIV Association guidelines for the routine investigation and monitoring of adult HIV-1-infected individuals 2011. HIV Med (2012) 2.05
Severe renal dysfunction and risk factors associated with renal impairment in HIV-infected adults in Africa initiating antiretroviral therapy. Clin Infect Dis (2008) 1.98
Tenofovir-associated renal and bone toxicity. HIV Med (2009) 1.82
Predictors of kidney tubular dysfunction in HIV-infected patients treated with tenofovir: a pharmacogenetic study. Clin Infect Dis (2009) 1.81
Kidney tubular abnormalities in the absence of impaired glomerular function in HIV patients treated with tenofovir. AIDS (2009) 1.81
Impact of tenofovir on renal function in HIV-infected, antiretroviral-naive patients. J Acquir Immune Defic Syndr (2010) 1.74
Renal safety of tenofovir in HIV treatment-experienced patients. AIDS (2004) 1.50
Antiretroviral therapy in the treatment of HIV-associated nephropathy. Nephrol Dial Transplant (2006) 1.49
Suppression of HIV-1 replication by antiretroviral therapy improves renal function in persons with low CD4 cell counts and chronic kidney disease. AIDS (2008) 1.46
HIV-infected persons continue to lose kidney function despite successful antiretroviral therapy. AIDS (2009) 1.41
Kidney function and the risk of cardiovascular events in HIV-1-infected patients. AIDS (2010) 1.37
Microalbuminuria is associated with all-cause and AIDS mortality in women with HIV infection. J Acquir Immune Defic Syndr (2010) 1.37
Urinary NGAL marks cystic disease in HIV-associated nephropathy. J Am Soc Nephrol (2009) 1.34
HIV viremia and changes in kidney function. AIDS (2009) 1.32
Impairment in kidney tubular function in patients receiving tenofovir is associated with higher tenofovir plasma concentrations. AIDS (2010) 1.24
Spectrum of chronic kidney disease in HIV-infected patients. HIV Med (2009) 1.24
Predictors of renal outcome in HIV-associated nephropathy. Clin Infect Dis (2008) 1.21
Genetic variants of ABCC10, a novel tenofovir transporter, are associated with kidney tubular dysfunction. J Infect Dis (2011) 1.18
Microalbuminuria and chronic kidney disease as risk factors for cardiovascular disease. Nephrol Dial Transplant (2006) 1.07
Subclinical tubular injury in HIV-infected individuals on antiretroviral therapy: a cross-sectional analysis. Am J Kidney Dis (2009) 1.06
Recent developments in HIV and the kidney. Curr Opin Infect Dis (2009) 1.06
Immunodeficiency and renal impairment are risk factors for HIV-associated acute renal failure. AIDS (2010) 0.95
Kidney tubular damage in the absence of glomerular defects in HIV-infected patients on highly active antiretroviral therapy. Nephrol Dial Transplant (2011) 0.95
Biomarkers of impaired renal function. Curr Opin HIV AIDS (2010) 0.93
Clinical epidemiology of HIV-associated end-stage renal failure in the UK. AIDS (2009) 0.91
The nephrologist in the HAART era. AIDS (2007) 0.81
Urinary NGAL is a useful clinical biomarker of HIV-associated nephropathy. Nephrol Dial Transplant (2011) 0.81
Urinary cystatin C can improve the renal safety follow-up of tenofovir-treated patients. AIDS (2009) 0.80
Analysis of molecular forms of urine Retinol-Binding Protein in Fanconi Syndrome and design of an accurate immunoassay. Clin Chim Acta (2011) 0.78
Acute skeletal muscle wasting in critical illness. JAMA (2013) 6.38
A randomized placebo-controlled trial of methotrexate in psoriatic arthritis. Rheumatology (Oxford) (2012) 3.56
Differential expression of iron-, carbon-, and oxygen-responsive mycobacterial genes in the lungs of chronically infected mice and tuberculosis patients. Proc Natl Acad Sci U S A (2003) 3.14
Mycobacterium tuberculosis growth at the cavity surface: a microenvironment with failed immunity. Infect Immun (2003) 3.01
Efavirenz is associated with severe vitamin D deficiency and increased alkaline phosphatase. AIDS (2010) 2.57
Tenofovir-associated kidney toxicity in HIV-infected patients: a review of the evidence. Am J Kidney Dis (2011) 2.56
Risk factors and outcomes for late presentation for HIV-positive persons in Europe: results from the Collaboration of Observational HIV Epidemiological Research Europe Study (COHERE). PLoS Med (2013) 2.49
An inflammatory biomarker as a differential predictor of outcome of depression treatment with escitalopram and nortriptyline. Am J Psychiatry (2014) 2.43
Hereditary fibrinogen A alpha-chain amyloidosis: phenotypic characterization of a systemic disease and the role of liver transplantation. Blood (2009) 2.30
A new mechanism for bile acid diarrhea: defective feedback inhibition of bile acid biosynthesis. Clin Gastroenterol Hepatol (2009) 2.25
Remote intermittent ischemia before coronary artery bypass graft surgery: a strategy to reduce injury and inflammation? Basic Res Cardiol (2011) 1.81
Mortality from HIV and TB coinfections is higher in Eastern Europe than in Western Europe and Argentina. AIDS (2009) 1.81
Leptin is an endothelial-independent vasodilator in humans with coronary artery disease: Evidence for tissue specificity of leptin resistance. Eur Heart J (2006) 1.81
Opportunistic and systematic screening for chlamydia: a study of consultations by young adults in general practice. Br J Gen Pract (2006) 1.75
Investigating Black-White differences in prostate cancer prognosis: A systematic review and meta-analysis. Int J Cancer (2008) 1.73
The differential role of Smad2 and Smad3 in the regulation of pro-fibrotic TGFbeta1 responses in human proximal-tubule epithelial cells. Biochem J (2006) 1.72
The risk of prostate cancer amongst black men in the United Kingdom: the PROCESS cohort study. Eur Urol (2007) 1.62
Baseline kidney function as predictor of mortality and kidney disease progression in HIV-positive patients. Am J Kidney Dis (2012) 1.62
The risk of prostate cancer amongst South Asian men in southern England: the PROCESS cohort study. BJU Int (2008) 1.53
Renal tubular disease in the era of combination antiretroviral therapy. AIDS (2015) 1.44
Sodium-glucose cotransporter-2 inhibitors and blood pressure decrease: a valuable effect of a novel antidiabetic class? J Hypertens (2015) 1.42
Direct stenting may limit myocardial injury during percutaneous coronary intervention. J Invasive Cardiol (2003) 1.39
Intervention Associated Acute Kidney Injury and Long-Term Cardiovascular Outcomes. Am J Nephrol (2015) 1.39
Beneficial effects of oral magnesium supplementation on insulin sensitivity and serum lipid profile. Med Sci Monit (2010) 1.27
The quest for modernisation of traditional Chinese medicine. BMC Complement Altern Med (2013) 1.24
Sub-optimal CD4 reconstitution despite viral suppression in an urban cohort on antiretroviral therapy (ART) in sub-Saharan Africa: frequency and clinical significance. AIDS Res Ther (2008) 1.22
Predictors of renal outcome in HIV-associated nephropathy. Clin Infect Dis (2008) 1.21
High rate of loss to clinical follow up among African HIV-infected patients attending a London clinic: a retrospective analysis of a clinical cohort. J Int AIDS Soc (2010) 1.21
In vitro anti-fibrotic activities of herbal compounds and herbs. Nephrol Dial Transplant (2009) 1.18
HIV care and the incidence of acute renal failure. Clin Infect Dis (2008) 1.18
TGF-beta1-induced connective tissue growth factor (CCN2) expression in human renal proximal tubule epithelial cells requires Ras/MEK/ERK and Smad signalling. Nephron Exp Nephrol (2005) 1.14
Effects of vitamin D deficiency and combination antiretroviral therapy on bone in HIV-positive patients. AIDS (2012) 1.14
Mycobacterium tuberculosis H37Ra and H37Rv differential growth and cytokine/chemokine induction in murine macrophages in vitro. J Interferon Cytokine Res (2006) 1.14
The controversial effects of thiazolidinediones on cardiovascular morbidity and mortality. Int J Cardiol (2008) 1.14
Effects of low-dose atorvastatin on arterial stiffness and central aortic pressure augmentation in patients with hypertension and hypercholesterolemia. Am J Hypertens (2013) 1.12
Increase in oxidative stress but not in antioxidant capacity with advancing stages of chronic kidney disease. Am J Nephrol (2007) 1.11
Cardiac troponin T and I and creatine kinase-MB as markers of myocardial injury and predictors of outcome following percutaneous coronary intervention. Int J Cardiol (2003) 1.09
Switching to Tenofovir Alafenamide, Coformulated With Elvitegravir, Cobicistat, and Emtricitabine, in HIV-Infected Patients With Renal Impairment: 48-Week Results From a Single-Arm, Multicenter, Open-Label Phase 3 Study. J Acquir Immune Defic Syndr (2016) 1.08
Rho isoforms have distinct and specific functions in the process of epithelial to mesenchymal transition in renal proximal tubular cells. Cell Signal (2009) 1.07
Faecal calprotectin: a noninvasive diagnostic tool and marker of severity in pouchitis. Eur J Gastroenterol Hepatol (2008) 1.07
Microalbuminuria and chronic kidney disease as risk factors for cardiovascular disease. Nephrol Dial Transplant (2006) 1.07
The impact of disease activity, pain, disability and treatments on fatigue in established rheumatoid arthritis. Clin Rheumatol (2011) 1.03
Plasma citrulline concentration: a reliable marker of small bowel absorptive capacity independent of intestinal inflammation. Am J Gastroenterol (2007) 1.03
Endothelial function and weight loss in obese humans. Obes Surg (2005) 1.03
Carvedilol in hypertension treatment. Vasc Health Risk Manag (2008) 1.02
Human serum IgA1 is substituted with up to six O-glycans as shown by matrix assisted laser desorption ionisation time-of-flight mass spectrometry. Carbohydr Res (2004) 1.02
Short echo time proton magnetic resonance spectroscopy in Alzheimer's disease: a longitudinal multiple time point study. Brain (2010) 1.01
HIV-1 infection and the kidney: an evolving challenge in HIV medicine. Mayo Clin Proc (2007) 1.01
The regulation of mesangial cell proliferation. Nephron Exp Nephrol (2008) 1.00
Ammonia clearance with haemofiltration in adults with liver disease. Liver Int (2013) 1.00
Sexual behaviour of people living with HIV in London: implications for HIV transmission. AIDS (2007) 0.99
Disclosure of HIV status: the role of ethnicity among people living with HIV in London. J Acquir Immune Defic Syndr (2008) 0.97
Antiretrovirals and the kidney in current clinical practice: renal pharmacokinetics, alterations of renal function and renal toxicity. AIDS (2014) 0.97
Prediction of cognitive dysfunction after resuscitation from out-of-hospital cardiac arrest using serum neuron-specific enolase and protein S-100. Heart (2007) 0.97
A systematic review of definitions of extreme phenotypes of HIV control and progression. AIDS (2014) 0.96
Immunodeficiency and renal impairment are risk factors for HIV-associated acute renal failure. AIDS (2010) 0.95
Aspartate aminotransferase-to-platelet ratio index is a powerful predictor of mortality among HIV-positive patients. J Infect Dis (2012) 0.95
Potent stimulation of fibroblast growth factor 19 expression in the human ileum by bile acids. Am J Physiol Gastrointest Liver Physiol (2013) 0.95
Short-term oral folic acid supplementation enhances endothelial function in patients with type 2 diabetes. Am J Hypertens (2005) 0.94
Comparison of CKD-EPI and MDRD to estimate baseline renal function in HIV-positive patients. Nephrol Dial Transplant (2011) 0.94
Effects of thiazolidinediones beyond glycaemic control. Curr Pharm Des (2009) 0.93
Gender disparity in outcomes of care and management for diabetes and the metabolic syndrome. Curr Diab Rep (2006) 0.93
Quantifying leukocytes in first catch urine provides new insights into our understanding of symptomatic and asymptomatic urethritis. Int J STD AIDS (2006) 0.93
Oral magnesium supplementation reduces ambulatory blood pressure in patients with mild hypertension. Am J Hypertens (2009) 0.92
The effect of bariatric surgery on intestinal absorption and transit time. Obes Surg (2014) 0.91
The clinical relevance of raised cardiac troponin I in the absence of significant angiographic coronary artery disease. Int J Cardiol (2005) 0.91
Differences between office and 24-hour blood pressure control in hypertensive patients with CKD: A 5,693-patient cross-sectional analysis from Spain. Am J Kidney Dis (2013) 0.91
Clinical epidemiology of HIV-associated end-stage renal failure in the UK. AIDS (2009) 0.91
Renal biopsy in liver transplant recipients. Nephrol Dial Transplant (2009) 0.90
Acute kidney injury in patients admitted to a liver intensive therapy unit with paracetamol-induced hepatotoxicity. Nephrol Dial Transplant (2011) 0.89
Remission in early rheumatoid arthritis: predicting treatment response. J Rheumatol (2012) 0.89
Hemodialysis reduces augmentation index but not aortic or brachial pulse wave velocity in dialysis-requiring patients. Am J Nephrol (2011) 0.89
Signaling: focus on Rho in renal disease. J Am Soc Nephrol (2003) 0.88
Ras antagonist farnesylthiosalicylic acid (FTS) reduces glomerular cellular proliferation and macrophage number in rat thy-1 nephritis. J Am Soc Nephrol (2003) 0.88
Diarrhea in Crohn’s disease: investigating the role of the ileal hormone fibroblast growth factor 19. J Crohns Colitis (2015) 0.86
Pain thresholds in rheumatoid arthritis: the effect of tender point counts and disease duration. J Rheumatol (2011) 0.86
Current limitations in the management of cardiovascular risk in rheumatoid arthritis. Clin Exp Rheumatol (2012) 0.86
Late HIV diagnosis is a major risk factor for intensive care unit admission in HIV-positive patients: a single centre observational cohort study. BMC Infect Dis (2013) 0.86
Traditional Chinese medicine research in the post-genomic era: good practice, priorities, challenges and opportunities. J Ethnopharmacol (2012) 0.86
Higher circulating bile acid concentrations in obese patients with type 2 diabetes. Ann Clin Biochem (2013) 0.86
HIV-related discrimination reported by people living with HIV in London, UK. AIDS Behav (2007) 0.86
Resolution of HIV-associated adult lymphocytic interstitial pneumonitis in pregnancy. AIDS (2008) 0.86
Glycoform composition profiling of O-glycopeptides derived from human serum IgA1 by matrix-assisted laser desorption ionization-time of flight-mass spectrometry. Anal Biochem (2004) 0.86
Arterial stiffness: a novel cardiovascular risk factor in kidney disease patients. Curr Vasc Pharmacol (2015) 0.85
Cobicistat: a Novel Pharmacoenhancer for Co-Formulation with HIV Protease and Integrase Inhibitors. Infect Dis Ther (2013) 0.85
Ambulatory blood pressure monitoring: an invaluable tool comes of age for patients with chronic kidney disease? Am J Nephrol (2012) 0.85